معرفی
Dr. Kim O'Sullivan is a Senior Research Fellow and head of the Translational Kidney Therapies Group at the Centre for Inflammatory Diseases (CID), Monash Health Translational Precinct, affiliated with Monash University’s Faculty of Medicine, Nursing and Health Sciences. She holds a PhD in Immunology from Monash University and completed her undergraduate and Master’s studies in Anatomy and Structural Biology at the University of Otago, New Zealand. Her work is centered on developing novel therapies for autoimmune kidney diseases, particularly ANCA-associated vasculitis (AAV), glomerulonephritis, and lupus nephritis.
Her research focuses on:
- Neutrophil Extracellular Traps (NETs) and their role in inflammation
- Gene therapy using adeno-associated viral vectors to deliver DNase I
- Therapeutic potential of bacterial exosomes
- Gut microbiome interactions, especially Muribaculaceae and SCFAs
- Immune tolerance and host defense preservation
Her recent publications (2023–2024) reflect a strong trend in translational immunology, with emphasis on microbiome-immune crosstalk, novel biologics, and gene-based interventions. She has published in high-impact journals such as Frontiers in Immunology, International Journal of Molecular Sciences, and Journal of Immunology.
Her scientific contributions have been recognized through several awards:
- Australian and New Zealand Society of Nephrology Young Investigator Award (Winner, 2016)
- ANZSN Basic Science Award (Finalist, 2020)
- Multiple ANZSN Travel Awards (2014, 2016, 2017)
Kim O'Sullivan actively supervises Honours and PhD students and leads multiple research projects funded by NHMRC and MRFF. She serves on the ANZSN Scientific Programme and Awards Committee (SPARC), is a Review Editor for Frontiers in Immunology, and sits on the editorial boards of International Journal of Molecular Sciences and Journal of Integrated Medicine in Nephrology and Andrology. She is also a peer reviewer for top journals including Journal of Clinical Investigation and Kidney International.
She leads the CID weekly seminar series and chaired the ImmuMON21 symposium. Her commitment to equity in STEM includes mentoring through BrainSTEM and past involvement in the ANZSN Equity, Diversity and Inclusion Committee.
